Cargando…

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy

Conjugates between photosensitisers (PS) and charged polymeric carriers are under investigation for photodynamic therapy of cancer and may allow targeting to certain cell types or compartments in tumours. Covalent attachment of polyethylene glycol to macromolecules (pegylation) may alter their pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamblin, M R, Miller, J L, Rizvi, I, Loew, H G, Hasan, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394480/ https://www.ncbi.nlm.nih.gov/pubmed/12942129 http://dx.doi.org/10.1038/sj.bjc.6601210

Ejemplares similares

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model
por: Borle, F, et al.
Publicado: (2003)

ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures
por: Casas, A, et al.
Publicado: (2002)

Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003)

Photodynamic Therapy and the Development of Metal-Based Photosensitisers
por: Josefsen, Leanne B., et al.
Publicado: (2008)

Relationship between subcellular localisation of Foscan® and caspase activation in photosensitised MCF-7 cells
por: Marchal, S, et al.
Publicado: (2007)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
por: van Geel, I. P., et al.
Publicado: (1995)

Combination of Two Photosensitisers in Anticancer, Antimicrobial and Upconversion Photodynamic Therapy
por: Mušković, Martina, et al.
Publicado: (2023)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study
por: Lüdicke, F, et al.
Publicado: (2003)

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Role of cytokines in photodynamic therapy-induced local and systemic inflammation
por: Gollnick, S O, et al.
Publicado: (2003)

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy
por: Castano, A P, et al.
Publicado: (2006)

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002)

(213)Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model
por: Li, Y, et al.
Publicado: (2002)

Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma
por: Otake, M, et al.
Publicado: (2003)

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002)

Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy
por: Chiu, S-M, et al.
Publicado: (2003)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma
por: Ickowicz Schwartz, D, et al.
Publicado: (2004)

Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model
por: Harrington, K J, et al.
Publicado: (2004)

Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen
por: Reginato, E, et al.
Publicado: (2013)

Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.
por: Kessel, D., et al.
Publicado: (1995)

Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy
por: Kruger, Cherie Ann, et al.
Publicado: (2018)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
por: Lu, Jingjing, et al.
Publicado: (2019)

The Photosensitising Action of Chemical Carcinogens
por: Calcutt, G.
Publicado: (1954)

Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers – a comparative study
por: BALDEA, IOANA, et al.
Publicado: (2015)

Design and Characterisation of pH-Responsive Photosensitiser-Loaded Nano-Transfersomes for Enhanced Photodynamic Therapy
por: Yeo, Sooho, et al.
Publicado: (2022)

Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.
por: Milanesi, C., et al.
Publicado: (1990)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

Irradiance uniformity optimization for a photodynamic therapy treatment device with 3D scanner
por: Wang, Xu, et al.
Publicado: (2021)

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
por: Dev, I K, et al.
Publicado: (2004)

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
por: Gil, M, et al.
Publicado: (2011)

Alkaloids as Photosensitisers for the Inactivation of Bacteria
por: López-Molina, Sònia, et al.
Publicado: (2021)

NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus
por: Mercer, Derry K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g719o7ggg7kb5t8q26vjbfjgen